LYCOS RETRIEVER 
University of Toronto: Research
built 440 days ago
These and other quality-of-life adjustments affect patients as well as their partners and aren't easily resolved in the doctor's office, says Tia Higano, M.D., a University of Washington (UW) prostate-cancer specialist and associate in clinical research at Fred Hutchinson. Higano decided she wanted to do more to help. She found her answer in UW psychologist Sylvie Aubin, Ph.D. Aubin sits in on Higano's patient consults and offers prostate-cancer patients and their partners a "toolbox" of strategies to cope with challenges that are often hard to talk about. They see their patients at the Seattle Cancer Care Alliance, a patient-care partnership of Fred Hutchinson, the UW and Children's Hospital and Regional Medical Center located on the Fred Hutchinson campus. "Men can live a long time after treatment for prostate cancer, and they deserve to have a good quality of life," said Aubin, an acting instructor in the UW Department of Psychiatry and Behavioral Sciences. "But it's often very hard to get men to open up about these problems, which is the first step.
Source:
The Department of Biochemistry at the University of Toronto is a modern, research-intensive enterprise within the Faculty of Medicine. The Department was founded in 1907-08 and has a proud tradition of excellence in research and in teaching. For a brief history of the Department click HERE. Today, the Department boasts a large faculty (over 50 members and growing) whose research spans the breadth that is biochemistry today. There are a number of foci of research activity in the Department that include the University's Medical Sciences Building, the Banting and Best Department of Medical Research, the Research Institute at the Hospital for Sick Children, the Ontario Cancer Institute at Princess Margaret Hospital, the Samuel Lunenfeld Research Institute at Mt. Sinai and other sites in the University of Toronto community.
Source:
A research team from Uppsala University and AstraZeneca has found that the schizophrenia gene QKI affects the production of myelin, the material that insulates nerve fibers. It is hoped that these findings will lead to enhanced treatment of schizophrenia. The findings are being published in the Net edition of PNAS (Proceedings of the National Academy of Sciences) in mid-April. The research group has previously shown that the QKI gene is a possible contributing cause of the disease schizophrenia. Now the scientists have found that QKI normally regulates the myelin genes, that is, the genes that govern the production of myelin, the insulation material for nerve fibers. Moreover, the research team can show that the genetic expression of QKI is altered in schizophrenic patients and that the change correlates directly with the change in the myelin gene expression.
Source:
The University of Toronto Library system is the largest academic library in Canada and is ranked in the top five among research libraries in North America. The system consists of over 30 libraries located on three university campuses with a collection of more than 15 million items. The Robarts Library and the Thomas Fisher Rare Book Library attract scholars from around the world.
Source:
In light of a World Bank study on the role universities can play in boosting the economies of developing countries, the president of the Association of African Universities (AAU), George Eshiwani, urged African governments to commit more resources to university research. Eshiwani explained at the 57th AAU Executive Board Meeting that universities are "vehicles for socio-economic development." According to the article, the AAU president expressed regret that in spite of the World Bank findings, African universities continue to have little resources allocated to them for research work, compared to their counterparts in developed countries. Eshiwani, who is ... the vice-chancellor of the Kenyatta University in Kenya, asked African governments to "invest heavily" in universities so that in the future Africans can find solutions to socio-economic challenges such as those posed by HIV/AIDS, famine, and conflicts.
Source:
Joachim Kohn Professor Kohn is a Board of Governors Professor of Chemistry and Chemical Biology at Rutgers University and an Adjunct Associate Professor of Orthopedics at the New Jersey Medical School. He currently serves as director of the New Jersey Center for Biomaterials and is a member of the board of governors of the Association of Institutions for Materials Science (AIMS). He is a fellow of the American Institute for Medical and Biological Engineering (AIMBE) and served as the secretary-treasurer of the Society for Biomaterials. He is the principal investigator of an NIH funded postdoctoral training program in tissue engineering and implant science. His research interests focus on the development of new biomaterials for prostheses, implantable drug or gene delivery systems, and tissue regeneration scaffolds. He has published 167 scientific manuscripts and reviews, and holds 31 patents.
Source:
MORE ABOUT
Research